Coronavirus and multiple sclerosis - update
The Belgian Charcot Foundation follows the advice of the Belgian Study Group for MS regarding the treatment of MS patients.
Multiple sclerosis (MS) is the most common neurological disorder among young adults and often results in a handicap. It is an auto-immune disease in which the body attacks its own tissues. The immune attack in MS targets the central nervous system. The lesions are well-localised and are called “plaques”.